1. Home
  2. WAT vs XPEV Comparison

WAT vs XPEV Comparison

Compare WAT & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • XPEV
  • Stock Information
  • Founded
  • WAT 1958
  • XPEV 2015
  • Country
  • WAT United States
  • XPEV China
  • Employees
  • WAT N/A
  • XPEV N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • XPEV Auto Manufacturing
  • Sector
  • WAT Industrials
  • XPEV Consumer Discretionary
  • Exchange
  • WAT Nasdaq
  • XPEV Nasdaq
  • Market Cap
  • WAT 17.4B
  • XPEV 21.7B
  • IPO Year
  • WAT 1995
  • XPEV 2020
  • Fundamental
  • Price
  • WAT $382.16
  • XPEV $24.88
  • Analyst Decision
  • WAT Buy
  • XPEV Buy
  • Analyst Count
  • WAT 13
  • XPEV 8
  • Target Price
  • WAT $379.00
  • XPEV $22.51
  • AVG Volume (30 Days)
  • WAT 652.9K
  • XPEV 15.6M
  • Earning Date
  • WAT 11-04-2025
  • XPEV 11-17-2025
  • Dividend Yield
  • WAT N/A
  • XPEV N/A
  • EPS Growth
  • WAT 3.82
  • XPEV N/A
  • EPS
  • WAT 10.88
  • XPEV N/A
  • Revenue
  • WAT $3,105,638,000.00
  • XPEV $8,416,181,216.00
  • Revenue This Year
  • WAT $7.12
  • XPEV $99.25
  • Revenue Next Year
  • WAT $6.22
  • XPEV $39.50
  • P/E Ratio
  • WAT $34.88
  • XPEV N/A
  • Revenue Growth
  • WAT 6.90
  • XPEV 66.37
  • 52 Week Low
  • WAT $275.05
  • XPEV $11.14
  • 52 Week High
  • WAT $423.56
  • XPEV $28.24
  • Technical
  • Relative Strength Index (RSI)
  • WAT 69.65
  • XPEV 55.04
  • Support Level
  • WAT $340.09
  • XPEV $21.60
  • Resistance Level
  • WAT $391.79
  • XPEV $28.20
  • Average True Range (ATR)
  • WAT 10.91
  • XPEV 1.29
  • MACD
  • WAT 1.20
  • XPEV 0.32
  • Stochastic Oscillator
  • WAT 80.12
  • XPEV 52.89

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About XPEV XPeng Inc.

Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 190,000 EVs in 2024, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.

Share on Social Networks: